SBIR [Phase II]: Development of Percutaneous DLC for Total Cavo-Pulmonary Assistance

Grants and Contracts Details

StatusFinished
Effective start/end date8/15/167/31/19

Funding

  • W-Z Biotech LLC: $306,183.00